Panel Discussion: Ensuring Fit for Purpose AI in Translational & Clinical Pathology to Accelerate Meaningful & Scalable Adoption
Time: 12:15 pm
day: Conference Day Two
Details:
- How does biopharma define and measure whether a digital pathology tool is fit for its intended use case in drug development or diagnostics?
- What benchmarking strategies help distinguish generalizable models from those validated for specific clinical or biomarker contexts?
- How can pathologists and data scientists work together to align model development with real-world use requirements?
Speakers:
